Results 171 to 180 of about 5,708 (209)

Brief Comparison of Novel Influenza Vaccine Design Strategies. [PDF]

Vaccines (Basel)
Chai S, Ye C, Fan C, Jiang H.
europepmc   +1 more source

Awareness, Attitudes, and Perceptions Toward Deceased Organ Donation Among Healthcare Students and Professionals: A Mixed-Methods Study. [PDF]

Cureus
Vg P, Mb A, Jayachandran M, Abraham EV, Iyer S.   +4 more
europepmc   +1 more source

Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination. [PDF]

Circulation
Fanti S, Dyer C, Ingimarsdóttir IJ, Harding D, Wang G, D'Amati A, Shahaj E, Sigurbergsdóttir AÝ, Thórsdóttir H, Gunnarsdóttir OB, Kanoni S, Wright P, Martin J, Chorlton J, Hollowood Z, Brynjólfsson SF, Lúdvíksson BR, Solito E, Bert S, Keane JM, Mohiddin SA, Longhi MP, Marelli-Berg FM.   +22 more
europepmc   +1 more source

Challenges and opportunities on achieving an adequate delivery efficiency and immunogenicity with peptide-based anticancer vaccines. [PDF]

Adv Drug Deliv Rev
Wang Y, Sun D, Laney V, Wang H, Wang LL, Lu ZR.   +5 more
europepmc   +1 more source

Acute and persistent responses after H5N1 vaccination in humans. [PDF]

Cell Rep
Apps R, Biancotto A, Candia J, Kotliarov Y, Perl S, Cheung F, Farmer R, Mulè MP, Rachmaninoff N, Chen J, Martins AJ, Shi R, Zhou H, Bansal N, Schum P, Olnes MJ, Milanez-Almeida P, Han KL, Sellers B, Cortese M, Hagan T, Rouphael N, Pulendran B, King L, Manischewitz J, Khurana S, Golding H, van der Most RG, Dickler HB, Germain RN, Schwartzberg PL, Tsang JS.   +31 more
europepmc   +1 more source

Advances in virus-like particle-based SARS-CoV-2 vaccines. [PDF]

Front Cell Infect Microbiol
Hao X, Yuan F, Yao X.
europepmc   +1 more source

Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralization. [PDF]

Immun Inflamm Dis
de Lima VA, Nunes JPS, Rosa DS, Ferreira R, Oliva MLV, Andreata-Santos R, Duarte-Barbosa M, Janini LMR, Maricato JT, Akamatsu MA, Ho PL, Schenkman S.   +11 more
europepmc   +1 more source

Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus. [PDF]

Vaccines (Basel)
Moon SY, Flores RA, Yim MS, Lim H, Kim S, Lee SY, Lee YK, Kim JO, Park H, Bae SE, Ouh IO, Kim WH.   +11 more
europepmc   +1 more source

Neurological Manifestations of Influenza Vaccination: A Narrative Review. [PDF]

Cureus
AlAli H, Ibrahim D, AlAttar W, Almualla M, Ghanim S, Robari F.   +5 more
europepmc   +1 more source

Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial. [PDF]

J Infect Dis
El Sahly HM, Yildirim I, Frey SE, Winokur P, Jackson LA, Bernstein DI, Creech CB, Chen WH, Rupp RE, Whitaker JA, Phadke V, Hoft DF, Ince D, Brady RC, Edwards KM, Ortiz JR, Berman MA, Weiss J, Wegel A, DMID 17-0090 Study Group.   +19 more
europepmc   +1 more source